SAN DIEGO (AP) — SAN DIEGO (AP) — Illumina Inc. (ILMN) on Thursday reported fourth-quarter net income of $187 million.
On a per-share basis, the San Diego-based company said it had net income of $1.17. Earnings, adjusted for non-recurring gains, were 86 cents per share.
The results fell short of Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of 92 cents per share.
The genetic testing tools company posted revenue of $1.1 billion in the period, which beat Street forecasts. Six analysts surveyed by Zacks expected $1.08 billion.
For the year, the company reported a loss of $1.22 billion, or $7.69 per share. Revenue was reported as $4.37 billion.
Illumina expects full-year earnings in the range of $4.50 to $4.65 per share.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ILMN at https://www.zacks.com/ap/ILMN
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.